Racial differences in long-term outcomes among black and white patients with drug-eluting stents - 14/07/19
, Hillary Mulder, MS b , Karen Chiswell, PhD b , Linda K. Shaw, MHS b , Tracy Y. Wang, MD, MHS a, b , Larry R. Jackson, MD a, b , Kevin L. Thomas, MD a, b Abstract |
Background |
Some studies suggest that black patients may have worse outcomes after drug-eluting stent (DES) placement. There are limited data characterizing long-term outcomes by race. The objective was to compare long-term outcomes between black and white patients after percutaneous coronary intervention (PCI) with DES implantation.
Methods |
We analyzed 915 black and 3,559 white (n = 4,474) consecutive patients who underwent DES placement at Duke University Medical Center from 2005 through 2013. Over 6-year follow up, we compared rates of myocardial infarction (MI), all-cause mortality, revascularization, and major bleeding between black and white patients. A multivariable Cox regression model was fit to adjust for potentially confounding variables. Dual-antiplatelet therapy use over time was determined by patient follow-up surveys and compared by race.
Results |
Black patients were younger; were more often female; had higher body mass indexes; had more diabetes mellitus, hypertension, and renal disease; and had lower median household incomes than white patients (P < .001). At 6 years after DES placement, black relative to white patients had higher unadjusted rates of MI (12.1% vs 10.1%, hazard ratio 1.25, 95% CI 1.00-1.57, P = .05) and major bleeding (17.8% vs 14.3%, hazard ratio 1.28, 95% CI 1.07-1.54, P = .01), but there were no significant differences in other outcomes. After multivariable adjustment, there were no statistically significant racial differences in any of these outcomes at 6 years. Similarly, dual-antiplatelet therapy use was comparable between racial groups.
Conclusions |
Unadjusted rates of MI and major bleeding over long-term follow up were higher among black patients compared to white patients, but these differences may be explained by racial differences in comorbid disease.
Il testo completo di questo articolo è disponibile in PDF.Mappa
| Akshay Bagai, MD, MHS, served as guest editor for this article. |
Vol 214
P. 46-53 - Agosto 2019 Ritorno al numero
Articolo precedente
- Participation in thrill-seeking activities by patients with hypertrophic cardiomyopathy: Individual preferences, adverse events and physician attitude
- Nikolaos Papoutsidakis, Stephen Heitner, Jodie Ingles, Christopher Semsarian, Meghan Mannello, Lisa Salberg, Cynthia Waldman, Benjamin Vaccaro, Niccolo Maurizi, Iacopo Olivotto, Daniel Jacoby
- Risk factors and prognostic impact of left ventricular assist device–associated infections
- Pierre Tattevin, Erwan Flécher, Vincent Auffret, Christophe Leclercq, Stéphane Boulé, André Vincentelli, Camille Dambrin, Clément Delmas, Laurent Barandon, Vincent Veniard, Michel Kindo, Thomas Cardi, Philippe Gaudard, Philippe Rouvière, Thomas Sénage, Nicolas Jacob, Pascal Defaye, Olivier Chavanon, Constance Verdonk, Marylou Para, Edeline Pelcé, Vlad Gariboldi, Matteo Pozzi, Daniel Grinberg, Arnaud Savouré, Pierre-Yves Litzler, Gerard Babatasi, Annette Belin, Fabien Garnier, Marie Bielefeld, David Hamon, Nicolas Lellouche, Louis Bernard, Thierry Bourguignon, Romain Eschalier, Nicolas D'Ostrevy, Jérôme Jouan, Emilie Varlet, Fabrice Vanhuyse, Hugues Blangy, Raphaël P. Martins, Vincent Galand
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?